HLA-C and neoplasm: CARs exhibit an exceptional capacity to detect surface molecules without requiring presentation or processing by major histocompatibility complex (MHC) molecules, thereby binding to tumor-specific antigens on the surface of malignant tumor cells upon specific recognition.